Antibiotic Resistance: A Growing Global Threat

     Antibiotic resistance is one of the most critical challenges facing global health today. As bacteria evolve mechanisms to evade the effects of antibiotics, previously treatable infections become increasingly difficult—and sometimes impossible—to cure. The rise of multidrug-resistant (MDR) and pan-resistant bacterial strains poses a serious threat to modern medicine, especially in hospitals and clinical settings.

How Resistance Develops

Bacteria can acquire resistance through two main pathways:

  • Vertical transmission: Genetic mutations passed from parent to daughter cells during replication.

  • Horizontal gene transfer: Bacteria can acquire resistance genes from other organisms via transformation, transduction, or conjugation.

These processes enable even non-pathogenic bacteria to serve as reservoirs of resistance genes, spreading them across species and environments.

Resistance Mechanisms

Bacteria have evolved diverse mechanisms to counteract antibiotics:

  • Enzymatic degradation or modification
    e.g., β-lactamases break down β-lactam antibiotics; aminoglycoside-modifying enzymes (e.g., acetyltransferases, phosphotransferases) deactivate aminoglycosides.

  • Target modification
    Mutations in antibiotic targets such as DNA gyrase, ribosomal RNA, or penicillin-binding proteins reduce antibiotic binding.

  • Efflux pumps
    These transport systems expel antibiotics from the bacterial cell, reducing intracellular concentrations. Families include ABC, MFS, RND, and MATE systems.

  • Reduced permeability
    Especially in Gram-negative bacteria, changes in porin proteins can block antibiotic entry.

  • Bypass pathways
    Bacteria may develop alternative biochemical routes to avoid inhibited steps targeted by antibiotics.

Notable Case Studies

  • Methicillin-resistant Staphylococcus aureus (MRSA): Resistance due to altered penicillin-binding protein (PBP2a), encoded by mecA gene.

  • Vancomycin-resistant Enterococci (VRE): Resistance via modification of the D-Ala-D-Ala cell wall precursor to D-Ala-D-Lac, reducing drug binding.

  • Carbapenem-resistant Enterobacteriaceae (CRE): These pathogens often carry NDM, KPC, or OXA-type carbapenemases, leading to near-total resistance.

Combating Resistance

Strategies to address antibiotic resistance include:

  • Antibiotic stewardship: Rational, evidence-based prescribing to minimize overuse and misuse.

  • Combination therapies: Use of synergistic drug pairs (e.g., β-lactam + β-lactamase inhibitor) to enhance efficacy.

  • Development of new drugs: Targeting novel bacterial processes, such as membrane integrity or RNA regulation.

  • Phage therapy and immunotherapy: Non-antibiotic approaches are being explored to supplement treatment.

    Antibiotic resistance is a natural evolutionary process, but it has been dramatically accelerated by human activities—especially the overuse of antibiotics in medicine and agriculture. Tackling resistance requires coordinated efforts across disciplines, sectors, and nations. Without immediate and sustained action, the world may enter a post-antibiotic era where common infections become untreatable.


References

Gallo, G., & Puglia, A. M. (2014). “Antibiotics and Resistance: A Fatal Attraction.” In Antibiotics: Targets, Mechanisms and Resistance, eds. C. O. Gualerzi et al., Wiley-VCH Verlag, pp. 73–101

.Note:

  • This article is still under development, and the information it contains may change as scientific research progresses.
  • Please be aware that specific details presented in this source may vary and require direct access to the original source for further information about the content described.

Komentar

Postingan populer dari blog ini

PEMERAN pendukung

Menjadi Normal